About GAIA

Gaia Healthcare was envisaged n conceptualized in 2016 to address unmet medical needs in Gulf Region with the aim of bringing cutting-edge products n services. The concept was initiated with an investment of 6 million USD in bringing a European model of techno-driven pharmaceutical distribution with as an initial investment with first mover advantage in the United Arab Emirates.

We are the largest vertically integrated pharmaceutical marketing & distribution company in the United Arab Emirates, with a cross-category ecosystem that covers In-licensing, Out-Licensing, Import, Registration, Marketing & Distribution of Pharmaceuticals in UAE & other Gulf countries through our distribution network.

Pioneering ground-breaking pharmaceutical distribution through connecting E-com technology with the best warehousing management systems coupled with the best logistics infrastructure including cold chain capabilities in UAE has allowed us to become the best player offering all the pharmaceutical distribution value chain under one umbrella.

It took a couple of years to become a significant player in pharmaceutical distribution in the United Arab Emirates, en route journey we invested in overseas manufacturing facilities, helping us acquire several marketing authorizations under our belt (MAHs).

In recent years we combined our imagination and advances in pharma technology enabled us to bring Innovator Pharmaceuticals, several First to file Generics in different therapeutic segments like Pediatrics, Gynecology, Orthopedics, Cardiology, Diabetology for UAE & GCC countries.

Company History

GAIA Healthcare is a UAE healthcare company founded in 2016 with a vision to improve global healthcare by developing innovative and high-quality pharmaceutical products. They have focused on establishing a strong foundation of scientific research, rigorous quality standards, and a customer-centric approach. Their flagship product, Mention, revolutionized the treatment landscape for the therapeutic area and provided new hope to patients worldwide. They have invested in state-of-the-art manufacturing partners, research and development, and laboratories worldwide, and have weathered market challenges and embraced opportunities for growth. They are grateful for the support and trust bestowed upon them by healthcare professionals, patients, and stakeholders, as it has motivated them to push the boundaries of what is possible in healthcare.

error: